These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10721386)

  • 1. 'Is this treatment worth while?' How to read the medical journals.
    Rheeder P; Ker JA
    S Afr Med J; 2000 Jan; 90(1):37-9. PubMed ID: 10721386
    [No Abstract]   [Full Text] [Related]  

  • 2. How to read clinical journals: IV. To determine etiology or causation.
    Can Med Assoc J; 1981 Apr; 124(8):985-90. PubMed ID: 7260801
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blinding in clinical trials.
    Ney PG
    CMAJ; 1989 Jan; 140(1):15. PubMed ID: 2909265
    [No Abstract]   [Full Text] [Related]  

  • 4. Designs for efficient clinical trials.
    Simon R
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data availability for industry sponsored trials: what should medical journals require?
    Steinbrook R; Kassirer JP
    BMJ; 2010 Oct; 341():c5391. PubMed ID: 20940213
    [No Abstract]   [Full Text] [Related]  

  • 6. Scientific misconduct in investigational drug trials.
    Shapiro MF; Charrow RP
    N Engl J Med; 1985 Mar; 312(11):731-6. PubMed ID: 3974649
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary: Journals must facilitate the dissemination and scrutiny of clinical research.
    Freemantle N
    BMJ; 2010 Oct; 341():c5397. PubMed ID: 20940214
    [No Abstract]   [Full Text] [Related]  

  • 8. A systematic survey of the quality of research reporting in general orthopaedic journals.
    Parsons NR; Hiskens R; Price CL; Achten J; Costa ML
    J Bone Joint Surg Br; 2011 Sep; 93(9):1154-9. PubMed ID: 21911523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ethics of randomization].
    Arpaillange P; Dion S
    Biomed Pharmacother; 1984; 38(9-10):426-9. PubMed ID: 6529599
    [No Abstract]   [Full Text] [Related]  

  • 10. The last patient in a drug trial.
    Hastings Cent Rep; 1981 Dec; 11(6):21-3. PubMed ID: 7333839
    [No Abstract]   [Full Text] [Related]  

  • 11. A framework establishing clear decision criteria for the assessment of drug efficacy.
    Huster WJ; Enas GG
    Stat Med; 1998 Aug 15-30; 17(15-16):1829-38. PubMed ID: 9749450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the clinical evaluation of antianxiety drugs. HEW (FDA) 77-3043, September 1977.
    Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):297-312. PubMed ID: 45205
    [No Abstract]   [Full Text] [Related]  

  • 13. Critique of the Guidelines for Clinical Evaluation of Antianxiety Drugs (HEW-FDA-77-3043).
    Cohn JB; Gottschalk LA
    Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):313-5. PubMed ID: 45206
    [No Abstract]   [Full Text] [Related]  

  • 14. The management of interim analyses in drug development.
    Facey KM; Lewis JA
    Stat Med; 1998 Aug 15-30; 17(15-16):1801-9; discussion 1811-2. PubMed ID: 9749448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Objective response criteria in phase II and phase III studies.
    Jones WG; Akaza H; Van Oosterom AT; Kotake T
    Prog Clin Biol Res; 1988; 269():243-60. PubMed ID: 3293063
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary: RECORD response.
    Coutts G
    BMJ; 2010 Oct; 341():c5409. PubMed ID: 20940216
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines for the evaluation of drugs in the elderly neuropsychiatric patients (demented and non-demented).
    Pharmacopsychiatria; 1981 Sep; 14(5):190-9. PubMed ID: 7291302
    [No Abstract]   [Full Text] [Related]  

  • 18. Providing evidence of efficacy for a new drug.
    Ruberg S; Cairns V
    Stat Med; 1998 Aug 15-30; 17(15-16):1813-23; discussion 1825-7. PubMed ID: 9749449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical reading and critical thinking--study design and methodology: a personal approach on how to read the clinical literature.
    Lipman TO
    Nutr Clin Pract; 2013 Apr; 28(2):158-64. PubMed ID: 23413301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.